IV Ozone Therapy Side Effects: What to Expect, Herxheimer Reactions & Risks
Explore the clinic directoryIn this article
- Key Takeaways
- What are the side effects of IV ozone therapy?
- Common Side Effects
- EBOO Therapy Side Effects
- Herxheimer Reactions
- Rare but Serious Risks
- Contraindications
- What to Watch for After Treatment
- Side Effects by Protocol Type
- Is IV ozone therapy FDA approved?
- How to lower your risk when choosing an ozone clinic
- Frequently Asked Questions
- Sources
The most common side effects of IV ozone therapy, whether delivered as major autohemotherapy (MAH), 10-pass or EBOO, are fatigue, bruising at the IV site, brief light-headedness and flu-like Herxheimer-type reactions, and most resolve within 24 to 48 hours. The most serious risk, gas embolism, is almost exclusively linked to improper technique, specifically the direct injection of ozone gas into a vein, which no trained ozone practitioner should ever do. G6PD deficiency is an absolute contraindication, so testing before the first session matters. Understanding these side effects, what causes them, and when they signal a problem helps patients make informed decisions and recognize when something needs attention.
What this article covers
This guide covers side effects specific to IV ozone delivery, including major autohemotherapy (MAH), 10-pass and EBOO (extracorporeal blood oxygenation and ozonation) protocols. Side effects from other ozone delivery routes (rectal insufflation, nasal insufflation, joint injection) are different and covered separately. For a comprehensive overview of all ozone therapy side effects across every delivery method, see the full guide on ozone therapy side effects.
Key Takeaways
- Most side effects are mild and temporary: Fatigue, bruising, and light-headedness are the most common IV ozone side effects and typically resolve within 24 to 48 hours, across MAH, 10-pass and EBOO.
- Herxheimer reactions are the most misunderstood side effect: Practitioners attribute post-session flu-like symptoms to pathogen die-off and immune activation, but controlled studies of this effect with ozone are lacking, so severe or lasting symptoms deserve a dose review rather than reassurance.
- Gas embolism is the most serious risk: It is caused by injecting gas directly into a vein, a technique error rather than an inherent risk of properly performed MAH, as ozone researcher Velio Bocci stressed in his safety reviews (2004, 2011).
- G6PD deficiency is an absolute contraindication: Patients with this enzyme deficiency cannot safely receive IV ozone because their red blood cells break down under oxidative stress. Testing should be done before the first session.
- Side effects tend to decrease with subsequent sessions: Reactions are usually strongest in the first 2 to 3 sessions and become milder as the body adapts to the hormetic stress.
- The FDA does not recognize a medical use for ozone: Federal regulation 21 CFR 801.415 describes ozone as a toxic gas with no known useful medical application, so IV ozone in the US is an unapproved, cash pay procedure.
What are the side effects of IV ozone therapy?
IV ozone therapy side effects fall into three groups: common and short-lived effects, Herxheimer-type reactions, and rare but serious complications. The common group includes fatigue, IV site bruising, light-headedness, mild nausea and, with citrate-based protocols, tingling around the mouth. These usually settle within a day or two.
The serious group includes gas embolism, hemolysis (red blood cell breakdown) and reactions in people with an undiagnosed contraindication such as G6PD deficiency. These are uncommon when a trained clinician uses a calibrated medical ozone generator and a closed system, but they are the reason screening and technique matter more than any other factor. The table below summarizes the pattern.
| Side effect | How common | Typical timing and duration |
|---|---|---|
| Fatigue | Most frequently reported | Starts 2 to 6 hours after treatment, lasts 12 to 48 hours |
| IV site bruising or tenderness | Common | Visible within hours, fades over several days |
| Light-headedness | Occasional | During reinfusion, resolves within minutes |
| Mild nausea | Occasional, more with 10-pass | During or shortly after treatment, transient |
| Herxheimer-type flu-like reaction | Variable, depends on the patient | Usually within 24 hours, typically settles within 48 to 72 hours |
| Citrate reaction (tingling, cramps) | Rare with MAH, more common with 10-pass | During or just after reinfusion, mild and temporary |
| Gas embolism, significant hemolysis | Rare, linked to technique or screening errors | Immediate to hours, requires emergency care |
Common Side Effects
Fatigue
Post-session fatigue is the most frequently reported side effect of IV ozone therapy. It typically begins 2 to 6 hours after treatment and can last 12 to 48 hours. The fatigue is usually described as a deep tiredness rather than acute exhaustion.
The cause is multifactorial. The immune activation triggered by ozone exposure requires energy. If pathogen die-off occurs, the body expends additional resources processing and eliminating debris. The hormetic stress response described by Sagai and Bocci (2011) temporarily taxes cellular energy systems.
Fatigue is generally most pronounced after the first 1 to 3 sessions and tends to diminish as the body adapts. Patients who experience significant fatigue are typically advised to rest on treatment days, stay hydrated, and schedule sessions when they can afford downtime.
Bruising at the IV Site
Like any IV procedure, MAH and 10-pass ozone therapy can cause bruising, tenderness, or a small hematoma at the puncture site. This is a mechanical side effect of venipuncture, not of ozone itself. The 10-pass method, which involves extended IV access over 60 to 90 minutes, may produce more site discomfort than standard single-pass MAH due to the longer needle time.
Patients who bruise easily (those on blood thinners, aspirin, fish oil, or with naturally fragile veins) should inform their practitioner before treatment. Using a larger, more stable vein and applying pressure after needle removal reduces bruising risk.
Light-headedness or Dizziness
Some patients feel briefly light-headed during or immediately after IV ozone, particularly during the reinfusion phase. This typically resolves within minutes. Contributing factors may include mild vasodilation from the ozone exposure, being in a reclined position for an extended period, dehydration, and anxiety (particularly during the first session).
Eating a light meal before treatment and staying well-hydrated helps prevent this. Patients should sit for a few minutes after treatment before standing.
Mild Nausea
A small percentage of patients experience mild nausea during or after IV ozone, particularly with higher doses (10-pass). This is usually transient and may be related to the speed of blood reinfusion, the patient’s sensitivity to the oxidative metabolites, or concurrent Herxheimer reactions. Ginger tea or a light snack after treatment often helps.
EBOO Therapy Side Effects
EBOO therapy side effects are largely the same as those of other IV ozone methods: fatigue, IV site bruising, light-headedness and Herxheimer-type flu-like symptoms, usually lasting 24 to 48 hours. EBOO stands for extracorporeal blood oxygenation and ozonation. Instead of ozonating a bag of blood, it circulates blood out of one vein, through a filter where oxygen and ozone are added, and back into another vein, in a setup that resembles a small dialysis circuit.
What is different about EBOO side effects?
Because EBOO runs blood continuously through tubing and a filter, it needs two points of venous access and an anticoagulant to keep the circuit from clotting. That makes bruising at both sites, bleeding in patients on blood thinners, and sensitivity to the anticoagulant more relevant than with a single MAH draw. Some patients notice a drop in blood pressure, chills or light-headedness while blood is outside the body, and practitioners typically monitor vital signs throughout.
The published evidence on EBOO is thin. Most of it comes from small case series and practitioner reports rather than controlled trials, so there is no reliable rate for any EBOO side effect. Screening is the same as for other IV ozone: G6PD testing, a review of anticoagulants and bleeding history, and a check for anemia. For a fuller explanation of how the procedure works, see the guide to EBOO ozone therapy, and for a side-by-side view of the two high-dose methods, read EBOO vs 10-pass ozone.
Herxheimer Reactions
The Jarisch-Herxheimer reaction is the most commonly discussed and most frequently misunderstood side effect of IV ozone therapy. Named after the dermatologists Adolf Jarisch (1895) and Karl Herxheimer, who described it in syphilis patients treated with mercury, a Herxheimer reaction occurs when rapid pathogen die-off releases endotoxins and inflammatory mediators faster than the body can process them.
The reaction is well documented with antibiotic treatment of spirochete infections such as syphilis and Lyme disease. Its occurrence after ozone is based mainly on practitioner observation. No controlled study has measured how often ozone causes a true Jarisch-Herxheimer reaction, so the label is a working explanation for post-session flu-like symptoms, not a confirmed diagnosis.
What It Feels Like
Herxheimer symptoms can include flu-like malaise (body aches, chills, low-grade fever), headache, increased fatigue beyond normal post-treatment tiredness, temporary worsening of existing symptoms, joint and muscle pain, brain fog, skin rashes or breakouts, and digestive upset.
Why It Happens with IV Ozone
Practitioners consider IV ozone particularly prone to triggering Herxheimer-type reactions because the ozone contacts blood directly, producing a systemic oxidative and immune signal. In patients with high pathogen loads (chronic Lyme disease, chronic viral reactivation, systemic candidiasis), they attribute the reaction to substantial die-off. The immune activation that ozone triggers also contributes: as the immune system ramps up, it may attack pathogens more aggressively, adding to the die-off cascade.
A mild, short-lived Herxheimer-type reaction is not by itself a sign that ozone therapy is harming you. Practitioners read it as pathogens dying and the body processing the debris. A reaction that is severe, lasts beyond 72 hours or keeps worsening is a reason to call your practitioner, not a sign to push through.
Managing Herxheimer Reactions
- Start low: Beginning with lower ozone concentrations and fewer passes (for 10-pass patients) reduces the initial die-off burden.
- Support detoxification: Adequate hydration, glutathione support (oral or IV), binders (activated charcoal, bentonite clay), and lymphatic support (dry brushing, gentle movement) are commonly used, though evidence for these supports is limited.
- Space sessions appropriately: Allow 48 to 72 hours between sessions to let the body clear die-off products.
- Communicate with your practitioner: Severe Herxheimer reactions may require dose adjustment or additional supportive therapies.
For a detailed guide on managing Herxheimer reactions from ozone therapy specifically, see the dedicated guide on ozone therapy Herxheimer reactions. Patients who want to tell die-off symptoms apart from other post-session effects can also read about ozone therapy detox symptoms.
Rare but Serious Risks
Air Embolism
Air embolism is the most serious potential complication of IV ozone therapy, and it is almost entirely preventable. It occurs when gas (air or ozone) is injected directly into a vein, forming a bubble that can travel to the heart, lungs, or brain and obstruct blood flow.
This risk exists specifically with the outdated practice of direct IV ozone injection (DIV), where ozone gas is pushed directly into a vein via syringe. Properly performed MAH does not carry this risk because the ozone is mixed with blood in an external container (bag or syringe) and then reinfused as ozone-treated blood, not as gas.
The 10-pass (Zotzmann) method uses a closed, pressurized system that also prevents direct gas injection. The blood is drawn out, ozonated under pressure in a sealed container, and returned to the patient as liquid, not gas. EBOO likewise returns blood through a filter circuit rather than injecting gas.
The key safety point: never allow a practitioner to push ozone gas directly into your vein via syringe. This technique is considered unsafe by mainstream ozone therapy organizations and has caused documented adverse events and fatalities.
Hemolysis
Ozone at excessively high concentrations can damage red blood cells (hemolysis). This is why therapeutic ozone concentrations are carefully controlled, typically staying within 20 to 70 mcg/mL for IV applications. At these concentrations, hemolysis is minimal and clinically insignificant according to Bocci’s work on ozone dosing (2004). Concentrations above this range can cause meaningful red blood cell destruction, which is one reason why calibrated, medical-grade ozone generators are essential.
Citrate Reaction
MAH and 10-pass protocols use sodium citrate as an anticoagulant to prevent blood from clotting in the container. Some patients are sensitive to citrate and may experience tingling around the mouth, numbness in the fingers, or muscle cramping during or after treatment. These symptoms are related to citrate binding calcium in the blood (transient hypocalcemia) and are usually mild and temporary. Slowing the reinfusion rate and taking oral calcium before treatment can help prevent citrate reactions.
Contraindications
Certain conditions make IV ozone therapy unsafe. These are absolute contraindications, not relative ones, and they apply to MAH, 10-pass and EBOO alike:
| Contraindication | Reason |
|---|---|
| G6PD (glucose-6-phosphate dehydrogenase) deficiency | This enzyme protects red blood cells from oxidative damage. Without it, ozone exposure causes severe hemolysis. G6PD testing should be performed before the first IV ozone session. |
| Active hyperthyroidism (uncontrolled) | Ozone may stimulate thyroid activity further, worsening hyperthyroid symptoms |
| Severe anemia | Drawing blood for MAH in severely anemic patients can worsen the anemia. The hemolytic stress of ozone, even at normal concentrations, adds additional burden. |
| Active hemorrhage or bleeding disorders | The anticoagulant (citrate) used in MAH and the blood draw itself are contraindicated in active bleeding |
| Pregnancy | Insufficient safety data. No ozone therapy during pregnancy. |
| Recent myocardial infarction | The hemodynamic changes from blood draw and reinfusion may stress a recently damaged heart |
Patients on anticoagulants such as warfarin or heparin, and those with a history of fainting during blood draws, are not automatically excluded, but they need a conversation with the treating clinician before the first session.
What to Watch for After Treatment
Most side effects from IV ozone therapy are self-limiting and resolve within 24 to 48 hours. Certain symptoms after treatment warrant immediate medical attention:
- Chest pain, sudden shortness of breath, or rapid heartbeat: Could indicate a rare cardiac or pulmonary event. Seek emergency care.
- Severe headache with vision changes: Especially if it comes on suddenly, this warrants evaluation.
- Prolonged bleeding or growing hematoma at the IV site: Pressure should stop bleeding within a few minutes. If it does not, contact your provider.
- Dark or blood-colored urine: Could indicate significant hemolysis. Contact your ozone practitioner and consider emergency evaluation.
- Herxheimer symptoms lasting more than 72 hours or worsening after 48 hours: May require dose adjustment or supportive intervention.
Side Effects by Protocol Type
| Side Effect | Standard MAH | 10-Pass |
|---|---|---|
| Fatigue | Mild to moderate | Moderate to significant |
| Herxheimer reaction | Mild to moderate | Often more intense (higher dose) |
| IV site bruising | Common | More common (longer IV time) |
| Nausea | Occasional | More frequent |
| Light-headedness | Occasional | More frequent |
| Citrate reaction | Rare | More common (more citrate used) |
The 10-pass method generally produces more intense side effects than standard MAH because the total ozone dose is significantly higher (up to 140,000 mcg vs. 2,000 to 15,000 mcg). Patients new to ozone therapy are often advised to start with standard MAH and progress to 10-pass after establishing tolerance. The protocol itself is explained in the guide to 10-pass ozone therapy.
What are the side effects of major autohemotherapy?
Major autohemotherapy side effects are usually the mildest of the IV ozone methods: short-lived fatigue, bruising at the single draw site, occasional light-headedness during reinfusion and, rarely, citrate tingling. In standard MAH, a clinician draws a measured volume of blood into a sterile bag or bottle, mixes it with a controlled ozone and oxygen dose, and drips it back into the same vein. Because the ozone is mixed outside the body, the gas embolism risk of direct injection does not apply. More detail is in the guide to MAH ozone therapy.
Is IV ozone therapy FDA approved?
IV ozone therapy is not FDA approved for any condition. The FDA regulation at 21 CFR 801.415 states that ozone is a toxic gas with no known useful medical application in specific, adjunctive or preventive therapy. Clinics in the US that offer MAH, 10-pass or EBOO do so as an unapproved, off label, cash pay service, and insurers generally do not cover it.
That status means side effect data come mostly from European practice, small studies and reviews such as Smith and colleagues (2017) and Cappello and colleagues (2020), not from FDA-reviewed trials. For the regulatory background, read whether ozone therapy is FDA approved.
How to lower your risk when choosing an ozone clinic
Most serious IV ozone complications trace back to screening gaps or poor technique, so the clinic matters as much as the protocol. Before booking, it is reasonable to ask:
- Who performs the IV access and the ozone procedure, and what is their license (MD, DO, NP, PA or RN)?
- Will I be tested for G6PD deficiency, or do you require a recent result?
- Do you use a calibrated medical ozone generator and a closed MAH, 10-pass or EBOO system?
- Do you ever inject ozone gas directly into a vein? The only acceptable answer is no.
- How do you monitor me during treatment, and what is your plan for a reaction?
The ozone therapy treatment guide covers indications, delivery routes and evidence in more depth. When you are ready to compare providers, the directory of ozone therapy clinics lists practices by state and city. Listing order there is not paid ranking, Featured slots are labeled and capped, Verified means the clinic completed credential checks rather than paid for placement, and the directory is free for patients. Inclusion in the directory is not an endorsement, so use the questions above with any clinic you contact.
Frequently Asked Questions
How long do IV ozone side effects last?
Most IV ozone side effects resolve within 24 to 48 hours. Fatigue usually starts 2 to 6 hours after a session and can last 12 to 48 hours, while mild Herxheimer-type symptoms are the longest-lasting common effect. IV site bruising may take several days to fade. If symptoms persist beyond 72 hours, or worsen after 48 hours, contact your practitioner so the dose or spacing between sessions can be reviewed.
Do side effects get better with more sessions?
Yes, side effects typically become milder with subsequent sessions. The first 2 to 3 sessions usually produce the strongest reactions, and practitioners attribute the improvement to the body adapting to the hormetic stress and, where present, a falling pathogen load. Many clinics start with a lower ozone concentration and increase it gradually for this reason. A reaction that gets stronger with each session is not the expected pattern and should be discussed with the treating clinician.
Should I get a G6PD test before starting?
Yes, a G6PD test before starting is essential. G6PD deficiency is an absolute contraindication for IV ozone therapy because affected red blood cells break down under oxidative stress, which can cause severe hemolysis. Any responsible practitioner will either test you or require proof of a recent G6PD result before your first session. It is a simple blood test available at any standard lab, and the result does not change over time.
Can IV ozone damage my veins?
Repeated venipuncture can cause mild scarring of veins over extended treatment courses, similar to any therapy requiring frequent IV access. Rotating sites and using experienced phlebotomists minimizes this. The 10-pass and EBOO methods involve longer needle time, so site soreness is more common with them. For patients requiring long treatment courses, some practitioners use a central line or PICC line, though this introduces its own risks, including infection and clotting.
What are the side effects of EBOO therapy?
EBOO therapy side effects mirror those of other IV ozone methods: fatigue, bruising at the two IV sites, light-headedness and Herxheimer-type flu-like symptoms that usually settle within 24 to 48 hours. Because blood runs through an external filter circuit, EBOO also requires an anticoagulant, which raises bleeding risk for people on blood thinners, and some patients feel chilled or notice a blood pressure dip during treatment. Published safety data on EBOO are limited to small studies and case reports.
Is a Herxheimer reaction after ozone therapy normal?
A mild Herxheimer-type reaction after ozone therapy is common and usually not dangerous. Symptoms such as body aches, chills, headache and temporary worsening of existing symptoms typically appear within a day and settle within 48 to 72 hours. Practitioners attribute them to pathogen die-off, although this has not been confirmed in controlled studies of ozone. Symptoms that are severe, last longer than 72 hours or keep worsening call for a call to your practitioner and possibly a lower dose.
Sources
- Bocci V. “Ozone as Janus: this controversial gas can be either toxic or medically useful.” Mediators of Inflammation, 2004. DOI:
- Sagai M, Bocci V. “Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress?” Medical Gas Research, 2011. DOI: 10.1186/2045-9912-1-29
- Smith NL, et al. “Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility.” Medical Gas Research, 2017. DOI: 10.4103/2045-9912.215752
- Jarisch A. “Therapeutische Versuche bei Syphilis.” Wiener Medizinische Wochenschrift, 1895.
- Cappello C, et al. “Ozone therapy: a potentially safe complementary/alternative treatment.” British Journal of Biomedical Science, 2020. DOI:
- US Food and Drug Administration. 21 CFR 801.415, “Maximum acceptable level of ozone.” Electronic Code of Federal Regulations